Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gyu-Jo Shim"'
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 46, Iss 1, Pp 1-14 (2024)
Abstract Background AMD3100, a CXCR4 antagonist, is currently prescribed for activating the mobilization of hematopoietic stem cells. Recently, AMD3100 was shown to potentiate bone morphogenetic protein-2 (BMP-2)-induced bone formation by stimulating
Externí odkaz:
https://doaj.org/article/1afedce43e97438d840127189db266e6
Publikováno v:
Applied Sciences, Vol 12, Iss 8, p 4035 (2022)
Medication-related osteonecrosis of the jaw (MRONJ) is a refractory disease, and a standard protocol for its treatment has not yet been established. In addition, owing to the old age of MRONJ patients and various complications, treatment goals focus
Externí odkaz:
https://doaj.org/article/624cdf24ba824dad824387af1e976414
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 39, Iss 1, Pp 1-4 (2017)
Abstract Background Postoperative infection occurs when bone graft material is dislodged into the maxillary sinus cavity and most of the patients are often uncomfortable with the drainage and irrigation procedures to eradicate the infection. In this
Externí odkaz:
https://doaj.org/article/2c5504e324a148b6b650ab228f58b920
Autor:
Seong Suk Jue, Gyu Jo Shim, Min-Ah Kim, Bilal Al-Nawas, Jae Eun Kim, Junho Jung, Yong-Dae Kwon, Youngjae Yoon
Publikováno v:
Journal of Cranio-Maxillofacial Surgery. 49:719-725
The aim of this study was to investigate the effect and timing of recombinant human parathyroid hormone analog (PTH) administration for preventing medication-related osteonecrosis of the jaws (MRONJ) using a murine model. After standardized MRONJ ind